{"schema_version":"1","generated_at":"2026-11-01T07:21:33.548Z","data_as_of":null,"url":"https://www.findmykol.com/kol/victor-yazbeck","json_url":"https://www.findmykol.com/kol/victor-yazbeck/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"victor-yazbeck","name":"Victor Yazbeck","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Virginia Commonwealth University","institution_url":"https://www.findmykol.com/institution/virginia-commonwealth-university","city":"Richmond","state":"VA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1154584662","orcid":"0000-0001-5113-8681","openalex":"A5075559357"},"summary":"Victor Yazbeck is an Oncology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 73 publications with 808 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":73,"cited_by_count":808,"h_index":14,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":16,"program_years":{"first":2021,"last":null},"rows_total":28,"shown":3,"withheld":25,"rows":[{"payer":"BeOne Medicines USA, Inc.","program_year":2025,"amount_usd":10275.9,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154584662"},{"payer":"Kite Pharma, Inc.","program_year":2025,"amount_usd":8483.21,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154584662"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":7121.09,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154584662"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1154584662","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":49.6,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":42.8,"drugs":[{"name":"Calquence","share_pct":47.1},{"name":"Brukinsa","share_pct":35.7},{"name":"Imbruvica","share_pct":17.2}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":6.8,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":19.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":22}]},{"area":"Anti-infectives","share_pct":13.6,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":13.6,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":11}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2024,"last":2024},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21CA270930","title":"Modeling Marginal Zone Lymphomagenesis","fiscal_year":2024,"amount_usd":"399187","organization":"VIRGINIA COMMONWEALTH UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R21CA270930"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study","year":2026,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025019115","status":"verified"},{"title":"Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment","year":2025,"journal":"Pilot and Feasibility Studies","source_url":"https://doi.org/10.1186/s40814-024-01580-7","status":"verified"},{"title":"Physical activity is associated with exercise capacity among patients undergoing chemotherapy: A pilot randomized controlled trial","year":2025,"journal":"PLoS ONE","source_url":"https://doi.org/10.1371/journal.pone.0329774","status":"verified"},{"title":"Physical activity is associated with exercise capacity among patients undergoing chemotherapy: A pilot randomized controlled trial","year":2025,"journal":"UNC Libraries","source_url":"https://doi.org/10.17615/b5ct-qx35","status":"verified"},{"title":"Etctn P10500: Phase 1 Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-199650","status":"verified"}],"source":"works"},"contact":{"address_1":"1250 E MARSHALL ST","address_2":"DEPT. OF INTERNAL MEDICINE-HEMATOLOGY/ONCOLOGY","city":"Richmond","state":"VA","zip":"232985051","phone":"804-828-7999","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1154584662","source":"identity"},"similar":[{"name":"Jasmohan Bajaj","slug":"jasmohan-bajaj","institution":"Virginia Commonwealth University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/jasmohan-bajaj","json_url":"https://www.findmykol.com/kol/jasmohan-bajaj/profile.json"},{"name":"Patrick Ching","slug":"patrick-ching","institution":"Virginia Commonwealth University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/patrick-ching","json_url":"https://www.findmykol.com/kol/patrick-ching/profile.json"},{"name":"Bruce Rubin","slug":"bruce-rubin","institution":"Virginia Commonwealth University","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/bruce-rubin","json_url":"https://www.findmykol.com/kol/bruce-rubin/profile.json"},{"name":"Arehzo Jahangiri","slug":"arehzo-jahangiri","institution":"Virginia Commonwealth University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/arehzo-jahangiri","json_url":"https://www.findmykol.com/kol/arehzo-jahangiri/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":25,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-10-14","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}